Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction
Function · 01.06.2026 · 7 (3)
DOI: 10.1152/function.113.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Function, erschienen am 01.06.2026. Verfasst von Gavin Power und 10 weiteren Autor:innen. Beteiligte Einrichtung: NextGen Precision Health, University of Missouri, Columbia, Missouri, United States. Hauptthemen laut MEDLINE: ADAM17 Protein, Hyaluronan Receptors, Mechanotransduction, Cellular, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Veterans Affairs Merit, American Heart Association.
Abstract (Originalsprache)
Impaired flow-mediated dilation (FMD) is an indicator of endothelial dysfunction in type 2 diabetes (T2D). However, the exact cellular and molecular mechanisms contributing to impaired mechanotransduction of shear stress in T2D are incompletely understood. This work supports the novel concept that increased endothelial activity of a disintegrin and metalloproteinase 17 (ADAM17) causes cleavage of cell-surface CD44, leading to loss of hyaluronan (HA)-associated shear stress mechanotransduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NextGen Precision Health, University of Missouri, Columbia, Missouri, United States.
- Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri, United States.
- Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, United States.
- Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Missouri, Columbia, Missouri, United States.
- Harry S. Truman Memorial Veteran's Hospital, Columbia, Missouri, United States.
ORCID-Profile: Gavin Power, Marc A Augenreich, Francisco I Ramirez-Perez, Larissa Ferreira-Santos, Luis A Martinez-Lemus, Jaume Padilla
Förderung
- NIH HHS
- Veterans Affairs Merit
- American Heart Association
- São Paulo Research Foundation
- FAPESP
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Power, G., Cho, M. J., Beltran-Ornelas, J. H., Augenreich, M. A., Imkaew, N., Lateef, O. M., Ramirez-Perez, F. I., Ferreira-Santos, L., Manrique-Acevedo, C., Martinez-Lemus, L. A., & Padilla, J. (2026). Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction. Function, 7(3). https://doi.org/10.1152/function.113.2025
Vancouver
Power G, Cho MJ, Beltran-Ornelas JH, Augenreich MA, Imkaew N, Lateef OM, et al. Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction. Function. 2026;7(3). doi:10.1152/function.113.2025
BibTeX
@article{Power2026,
author = {Power, Gavin and Cho, Min Jeong and Beltran-Ornelas, Jesus H and Augenreich, Marc A and Imkaew, Natnicha and Lateef, Olubodun M and Ramirez-Perez, Francisco I and Ferreira-Santos, Larissa and Manrique-Acevedo, Camila and Martinez-Lemus, Luis A and Padilla, Jaume},
title = {Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction},
journal = {Function},
year = {2026},
volume = {7},
number = {3},
doi = {10.1152/function.113.2025}
}
EUVIMED